Resonant Capital Advisors’s Boston Scientific BSX Stock Holding History

Resonant Capital Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$211K	Sell	4,948 -2,539	-34%	-$138K	0.01%	506
2026 Q1	$470K	Buy	7,487 +1,429	+24%	+$114K	0.02%	279
2025 Q4	$578K	Buy	6,058 +784	+15%	+$76.9K	0.03%	228
2025 Q3	$515K	Sell	5,274 -1,069	-17%	-$111K	0.03%	244
2025 Q2	$681K	Buy	6,343 +1,512	+31%	+$153K	0.04%	204
2025 Q1	$487K	Buy	4,831 +486	+11%	+$48.9K	0.03%	216
2024 Q4	$388K	Buy	4,345 +358	+9%	+$31.5K	0.03%	233
2024 Q3	$334K	Buy	3,987 +206	+5%	+$16.2K	0.02%	262
2024 Q2	$291K	Buy	3,781 +484	+15%	+$35.4K	0.02%	273
2024 Q1	$226K	Buy	+3,297	New	+$212K	0.02%	313

Other funds holding BSX

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Resonant Capital Advisors's BSX Position: Q2 2026 in Review

Resonant Capital Advisors reduced its Boston Scientific (BSX) stake by 34% in Q2 2026, selling an estimated $138K and leaving 4,948 shares worth $211K. The position accounts for 0.01% of the portfolio, ranked #506.

Resonant Capital Advisors first reported a position in BSX in Q1 2024 and has held it in 10 quarters since. The position peaked at $681K in Q2 2025. 614 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Resonant Capital Advisors held 4,948 shares of Boston Scientific worth $211K as of Q2 2026.
Resonant Capital Advisors sold 2,539 Boston Scientific shares in Q2 2026, an estimated $138K.
Boston Scientific made up 0.01% of Resonant Capital Advisors's portfolio in Q2 2026, its #506 holding.
Resonant Capital Advisors first reported a position in Boston Scientific in Q1 2024 and has held it in 10 quarters since.
Resonant Capital Advisors's Boston Scientific position peaked at $681K in Q2 2025.
614 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Resonant Capital Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.